Terms: = Uterine cancer AND FOXL2, BPES, 668, ENSG00000183770, P58012, PFRK, POF3, PINTO, BPES1 AND Treatment
21 results:
1. Evaluating the Prognostic Factors and Survival Rates of Endometrial cancer Patients in a Tertiary Referral Hospital in Northeast Thailand.
Wannasin R; Thinkhamrop K; Kelly M; Likitdee N
Asian Pac J Cancer Prev; 2024 Feb; 25(2):671-679. PubMed ID: 38415555
[TBL] [Abstract] [Full Text] [Related]
2. Survival benefit of surgery with postoperative radiotherapy in locally advanced cervical adenocarcinoma: a population-based analysis.
Wang X; Lu X; Chen J; Yi H; Lan Q
BMC Surg; 2023 Oct; 23(1):299. PubMed ID: 37789291
[TBL] [Abstract] [Full Text] [Related]
3. Association Between Oncology Clinical Pathway Utilization and Toxicity and Cost Outcomes in Patients With Metastatic Solid Tumors.
Liu Y; Mullangi S; Debono D; Chen X; Pham T; Fisch MJ; Gordon AS; Hershman DL
JCO Oncol Pract; 2023 Sep; 19(9):731-740. PubMed ID: 37384847
[TBL] [Abstract] [Full Text] [Related]
4. Application value of Ki67 and serum CA125 in the deep myometrial invasion of endometrial adenocarcinoma.
Qin L
BMC Cancer; 2023 Mar; 23(1):240. PubMed ID: 36918859
[TBL] [Abstract] [Full Text] [Related]
5. Establishment of a risk stratification model based on the combination of post-treatment serum squamous cell carcinoma antigen levels and FIGO stage of cervical cancer for treatment and surveillance decision-making.
Shi L; Liu Y; Li J; Kou J; Ouyang Y; Chen F; Huang X; Huo L; Huang L; Cao X
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5999-6007. PubMed ID: 36624190
[TBL] [Abstract] [Full Text] [Related]
6. Development and validation of a nomogram involving immunohistochemical markers for prediction of recurrence in early low-risk endometrial cancer.
Kong W; Tu Y; Jiang P; Huang Y; Zhang J; Jiang S; Li N; Yuan R
Int J Biol Markers; 2022 Dec; 37(4):395-403. PubMed ID: 36250543
[TBL] [Abstract] [Full Text] [Related]
7. Cost-effectiveness of pembrolizumab compared with chemotherapy in the US for women with previously treated deficient mismatch repair or high microsatellite instability unresectable or metastatic endometrial cancer.
Thurgar E; Gouldson M; Matthijsse S; Amonkar M; Marinello P; Upadhyay N; Nwankwo C; Aguiar-Ibáñez R
J Med Econ; 2021; 24(1):675-688. PubMed ID: 33866938
[TBL] [Abstract] [Full Text] [Related]
8. Risk of Recurrence After treatment for Cervical Intraepithelial Neoplasia 3 and Adenocarcinoma In Situ of the Cervix: Recurrence of CIN 3 and AIS of Cervix.
Swift BE; Wang L; Jembere N; Kupets R
J Low Genit Tract Dis; 2020 Jul; 24(3):252-258. PubMed ID: 32384365
[TBL] [Abstract] [Full Text] [Related]
9. Prevalence of Potentially Unnecessary Bimanual Pelvic Examinations and Papanicolaou Tests Among Adolescent Girls and Young Women Aged 15-20 Years in the United States.
Qin J; Saraiya M; Martinez G; Sawaya GF
JAMA Intern Med; 2020 Feb; 180(2):274-280. PubMed ID: 31904768
[TBL] [Abstract] [Full Text] [Related]
10. Does the extension of the type of hysterectomy contribute to the local control of endometrial cancer?
Hasegawa T; Furugori M; Kubota K; Asai-Sato M; Yashiro-Kawano A; Kato H; Oi Y; Shigeta H; Segawa K; Kitagawa M; Mine Y; Saji H; Numazaki R; Maruyama Y; Ohnuma E; Taniguchi H; Sugiura K; Miyagi E; Matsunaga T;
Int J Clin Oncol; 2019 Sep; 24(9):1129-1136. PubMed ID: 31069549
[TBL] [Abstract] [Full Text] [Related]
11. Combinative evaluation of primary tumor and lymph nodes in predicting pelvic lymphatic metastasis in early-stage cervical cancer: A multiparametric PET-CT study.
Li K; Sun H; Guo Q
Eur J Radiol; 2019 Apr; 113():153-157. PubMed ID: 30927941
[TBL] [Abstract] [Full Text] [Related]
12. SECOND cancer RISK FROM RADIATION THERAPY FOR COMMON SOLID TUMORS DIAGNOSED IN REPRODUCTIVE-AGED FEMALES.
Mazonakis M; Kachris S; Damilakis J
Radiat Prot Dosimetry; 2018 Dec; 182(2):208-214. PubMed ID: 29608744
[TBL] [Abstract] [Full Text] [Related]
13. Laparoscopic vs. open treatment of endometrial cancer in the elderly and very elderly: An age-stratified multicenter study on 1606 women.
Uccella S; Bonzini M; Palomba S; Fanfani F; Malzoni M; Ceccaroni M; Seracchioli R; Ferrero A; Berretta R; Vizza E; Sturla D; Roviglione G; Monterossi G; Casadio P; Volpi E; Mautone D; Corrado G; Bruni F; Scambia G; Ghezzi F
Gynecol Oncol; 2016 May; 141(2):211-217. PubMed ID: 26920107
[TBL] [Abstract] [Full Text] [Related]
14. [Comparison of safety and efficacy of laparoscopic versus abdominal radical hysterectomy in the treatment of patients with stage I a2-II b cervical cancer].
Yang L; Yang P; Li D; Cai J; Shen Y; Dong W; Zhang Y; Xiong Z; Chen H; Min J; Wang H; Wang Y; Liang W; Wang Z
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):915-22. PubMed ID: 26887875
[TBL] [Abstract] [Full Text] [Related]
15. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative.
Stelloo E; Bosse T; Nout RA; MacKay HJ; Church DN; Nijman HW; Leary A; Edmondson RJ; Powell ME; Crosbie EJ; Kitchener HC; Mileshkin L; Pollock PM; Smit VT; Creutzberg CL
Mod Pathol; 2015 Jun; 28(6):836-44. PubMed ID: 25720322
[TBL] [Abstract] [Full Text] [Related]
16. Volumetric MR-guided high-intensity focused ultrasound versus uterine artery embolisation for treatment of symptomatic uterine fibroids: comparison of symptom improvement and reintervention rates.
Ikink ME; Nijenhuis RJ; Verkooijen HM; Voogt MJ; Reuwer PJ; Smeets AJ; Lohle PN; van den Bosch MA
Eur Radiol; 2014 Oct; 24(10):2649-57. PubMed ID: 25117743
[TBL] [Abstract] [Full Text] [Related]
17. Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer.
Chai Y; Wang T; Wang J; Yang Y; Gao Y; Gao J; Gao S; Wang Y; Zhou X; Liu Z
BMC Cancer; 2014 Feb; 14():63. PubMed ID: 24495453
[TBL] [Abstract] [Full Text] [Related]
18. Clinical evaluation of neoadjuvant chemotherapy followed by radical surgery in the management of stage IB2-IIB cervical cancer.
Gong L; Lou JY; Wang P; Zhang JW; Liu H; Peng ZL
Int J Gynaecol Obstet; 2012 Apr; 117(1):23-6. PubMed ID: 22265255
[TBL] [Abstract] [Full Text] [Related]
19. Mutant p53 protein in the serum of patients with cervical carcinoma: correlation with the level of serum epidermal growth factor receptor and prognostic significance.
Oh MJ; Choi JH; Lee YH; Lee JK; Hur JY; Park YK; Lee KW; Chough SY; Saw HS
Cancer Lett; 2004 Jan; 203(1):107-12. PubMed ID: 14670624
[TBL] [Abstract] [Full Text] [Related]
20. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract] [Full Text] [Related]
[Next]
